Cipla Health Strengthens ProlyteORS Portfolio with Launch of Masala Guava Flavour
MUMBAI, India, March 24, 2026 /PRNewswire/ -- ProlyteORS, the W.H.O. recommended Oral Rehydration…
Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE Cell-Therapy Platform Toward First-in-Human Study
Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study…
Discovery Life Sciences and Mindpeak Partner to Bring AI Precision to Cancer Biomarker Testing in Global Clinical Trials
New alliance takes aim at inconsistent biomarker interpretation across pathologists, a persistent…
HERE Technologies joins DCSA+ as first mapping and location intelligence partner advancing digital standards in container trade
Amsterdam – HERE Technologies, the leading mapping and location data platform, today announced…
ONERugged Vehicle-Mounted Computer V82T Launches to Transform Fleet Management
SHENZHEN, China, March 24, 2026 (GLOBE NEWSWIRE) -- ONERugged, a brand of…
ConnectingtheWorld,DrivingApexGrowth:ApexmindSummit2026SuccessfullyHeldinHongKong
HongKong, March 24, 2026 (GLOBE NEWSWIRE) -- The Apexmind Summit 2026 was…
Protean ‘Digital Disruptors 2026’ honours visionary leaders redefining India’s financial ecosystem
ETBrandEquity.com and Protean eGov Technologies recognise trailblazers driving digital public infrastructure (DPI),…
Aptia and UST Earn ISG Paragon Award for Transformative Partnership
Partnership paves the way for disrupting traditional QA modelsBENGALURU, India and LONDON,…
Dupixent (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
Approval in moderate-to-severe patients was based on pivotal trial results showing over…
Idorsia announces the nomination of three candidates for election to the Board of Directors
Idorsia nominates three Board Directors with outstanding pharmaceutical industry, management and financial…
